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140letter to editorPapillary tumor of
the pineal region
presenting with Foster
Kennedy sign
To the Editor: Foster Kennedy
syndrome is deﬁned as unilateral
optic nerve atrophy, contralateral
disc edema and anosmia. It was
originally thought to be pathogno-
monic of space occupying lesions
in the anterior fossa causing direct
compression of the optic and olfac-
tory nerves and later intracranial
hypertension and contralateral disc
edema. Subsequent reports of non-
tumor and non-anterior fossa
causes, most commonly bilateral
sequential anterior ischemic optic
neuropathy, have been described.
We report a 29 year old man
who presented with unsteady gait
and diminution of vision over
2 months. He displayed ﬁndings
typical of Parinaud’s syndrome,
right disc edema and left optic
atrophy. MRI revealed a large
pineal tumor associated with
hydrocephalus and evidence of
increased intracranial pressure.
Papillary tumor of the pineal
region (PTPR) was diagnosed on
histopathology. To our knowledge,
this is the ﬁrst report of this very
rare tumor, occurring in associa-
tion with the Foster Kennedy sign.
Foster Kennedy syndrome
consists of a triad of optic atrophy,
contralateral optic nerve edema,
and anosmia.1 Originally, it was
thought to be pathognomonic of
anterior fossa masses, causing direct
compression and ipsilateral optic
atrophy followed by intracranial
hypertension with resultant contra-
lateral papilledema.Devoid of viable
neurons, the atrophic nerve fails to
swell, leading to the fundoscopic
disparity. Anosmia results from
concomitant compression of theproximal olfactory nerve. The fun-
doscopic ﬁndings, although rare,
have been reported in various
tumors and nontumor condi-
tions,1–7 and pseudo-Foster
Kennedy syndrome or Foster
Kennedy sign has been suggested
as a more accurate designation of
the isolated ocular manifestation.
Primary intracranial papillary
tumors are exceptionally rare.8
Papillary tumor of the pineal
region (PTPR), ﬁrst described in
2003,8 has been recently classiﬁed
by the World Health
Organization9 as a new histopath-
ologic entity, distinct from pineal
tumors. With less than 100 cases
reported, the typical clinicopatho-
logical spectrum and treatment
protocols have yet to be estab-
lished. Documenting PTPR cases
will broaden our understanding
of the spectrum of presentations
and natural course with manage-
ment implications that will ulti-
mately inﬂuence survival.
A 29-year-old previously
healthy man presented with a
4-month history of unsteady gait
and 6 weeks of rapidly progressive
asymmetric vision loss. He was alert
and oriented, with a Glasgow Coma
Score of 15/15 and completely
intact central and peripheral ner-
vous systems without reported
anosmia. Visual acuities were
20/30 (R) and no perception of
light (L), with bilateral dyschro-
matopsia [3/15 (R) and 0/15 (L)].
His extraocular movements were
full with modest limitations of
upgaze and convergence.
Optokinetic testing indicated con-
vergence–retraction nystagmus.
Pupils were sluggishly reactive to
light with a left afferent papillary
defect; however, they were briskly
reactive to attempted convergence,
exhibiting light-near dissociation.HemDilated ophthalmoscopy revealed a
grossly edematous right optic nerve
and a modestly edematous
(Figure 1A) and atrophic left optic
nerve with gliosis and decreased
arcuate nerve ﬁbers and ﬁne capil-
laries (Figure 1B). Subsequent
right visual ﬁelds revealed general
constriction. The anomalous eye
movements and pupillary reﬂexes
constitute Parinaud’s syndrome,
whereas the ophthalmoscopic ﬁnd-
ings represent the Foster Kennedy
sign. Systemic survey classiﬁed this
malignancy as localized without
metastases.
Contrast-enhanced neurora-
diologic assessments of the brain
and spinal columns revealed a large
heterogeneous mass in the pineal
region, compressing the tectal
plates of the brain stem and
occluding the aqueduct of Sylvius
with signiﬁcant hydrocephalus
and intracranial hypertension
(Figure 2A–C). The lateral and
third ventricles were grossly dis-
tended, with the latter hanging
low and appearing to compress
the adjacent optic nerves and chi-
asm (Figure 2C).
The tumor was surgically
debulked and a ventriculoperi-
toneal shunt was placed to manage
the hydrocephalus. Histopatho-
logic analysis revealed a low-grade
tumor with epithelial and neuroen-
docrine differentiation and focal
pseudopapillary pattern. Immuno-
histochemical staining was positive
for cytokeratin (AE1/AE3 and
CK18) and neural/neuroendocrine
markers [synaptophysin, neuroﬁla-
ment protein, CD56 (neural cell
adhesion molecule), and focal
chromogranin], and negative for
pan-germ cell markers (Figure 3).
These ﬁndings are compatible with
PTPR. The MIB-1 proliferation
index, a measure of proliferationatol Oncol Stem Cell Ther 8(3) Third Quarter 2015
Figure 2. (A) Brain and orbit magnetic resonance imaging, revealing a pineal region mass and hydrocephalus: (A) pre-contrast T2 axial view showing
a large heterogeneous pineal region mass and lateral and third ventriculomegaly (arrows) with bilateral orbital optic nerve swelling; (B) post-contrast
T1 axial view showing enhancement of the pineal mass; and (C) post-contrast T1 sagittal view showing lateral and third ventriculomegaly with low-
hanging optic recess of the third ventricle (arrow).
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Figure 1. (A) Dilated fundoscopy showing right optic disc edema and (B) left optic atrophy and evidence of old edema and perivascular gliosis and
loss of superficial capillaries. Compared with the right side, there are less arcuate bundles bilaterally to the left.
letter to editorand indicator of clinical behavior,
was 2%. The patient underwent
successful adjuvant radiation ther-
apy and recovery was uneventful
with complete resolution of
hydrocephalus and no interval pro-
gression on subsequent brain mag-
netic resonance imaging.
Foster Kennedy sign, a rare
ﬁnding with numerous etiologies,
most commonly results from bilat-
eral sequential anterior ischemic
optic neuropathy.1–3,6,7 In our
case, the anterior visual pathway
was affected from a remote site,
which suggests the involvement of
an indirect pathogenic mechanism.
Liang et al.10 proposed the follow-
ingHematol Oncol Stem Cell Ther 8(3) Third Quarter 201classiﬁcation concerning possible
pathogenic mechanisms for the
Foster Kennedy sign associated
with tumors: Type 1, direct optic
nerve compression and intracranial
hypertension as originally
described; Type 2, bilateral asym-
metric optic nerve compression;
and Type 3, no nerve compression
but asymmetric chronic papille-
dema. Variable contributions from
asymmetric chronic papilledema
and third ventriculomegaly com-
pression (Figure 2A–C) were
likely causes of this Foster
Kennedy sign.
PTPR, a newly recognized
distinct entity9 with both epithelial5and neuroendocrine components,
possibly represents aberrant prolif-
eration of specialized ependymal
cells in the subcommissural
organ.8 Most reports, case presen-
tations, and small series, present
with hydrocephalus and
Parinaud’s syndrome with local
recurrences, but tumor dissemina-
tion is rare.8,9 Anecdotal success
with various regimes, including
surgical excision, radiotherapy,
and chemotherapy, has been
described previously. However, an
evidence-based management pro-
tocol has yet to be established.
This case of PTPR presenting
exclusively with ophthalmic141
Figure 3. (A) Histology of the pineal region tumor depicting focal papillary architecture in low magnification. (B) Intermediate magnification shows a solid epithelial tumor
with minimal nuclear atypia and mitotic activity. The cells express (C) cytokeratin, (D) synaptophysin, (E) chromogranin, and (F) neurofilament protein.
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letter to editormanifestations of Parinaud’s syn-
drome and the Foster Kennedy
sign, by direct and indirect mass
effects, respectively, is a signiﬁcant
contribution to the catalog of pre-
sentations of this newly classiﬁed
and very rare tumor.CONFLICTS OF INTEREST
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